tradingkey.logo
tradingkey.logo
Search

Anbio Biotechnology

NNNN
Add to Watchlist
6.150USD
+0.090+1.49%
Close 09-24 16:00(ET)
269.92MMarket Cap
42.69P/E TTM

Anbio Biotechnology (NNNN) Revenue Performance

Updated: Dec 31, 2025

By Region

Annual
Annual
Quarterly
European Union
Asia Pacific
Other Regions
North America
South America
European Union
South America
North America
FY2025
FY2024
FY2023
FY2022
FY2021
European Union
5.15M(59.57%)
--(--)
--(--)
20.30M(86.23%)
4.09M(92.38%)
Asia Pacific
1.52M(17.58%)
509.17K(6.22%)
73.39K(1.09%)
3.19M(13.56%)
--(--)
Other Regions
1.41M(16.30%)
472.38K(5.77%)
111.05K(1.65%)
--(--)
--(--)
North America
296.20K(3.43%)
--(--)
--(--)
50.00K(0.21%)
337.50K(7.62%)
South America
269.54K(3.12%)
--(--)
--(--)
--(--)
--(--)
European Union
--(--)
5.62M(68.64%)
4.66M(69.44%)
--(--)
--(--)
South America
--(--)
1.48M(18.02%)
1.65M(24.61%)
--(--)
--(--)
North America
--(--)
110.51K(1.35%)
215.44K(3.21%)
--(--)
--(--)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.